Published in Radiology on October 01, 1999
Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report. Neurology (2009) 1.74
Premature carotid artery disease in pediatric cancer survivors treated with neck irradiation. Pediatr Blood Cancer (2009) 1.48
Valvular dysfunction and left ventricular changes in Hodgkin's lymphoma survivors. A longitudinal study. Br J Cancer (2009) 1.06
Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography. Cardiovasc Ultrasound (2007) 0.97
Effects of neck radiation therapy on extra-cranial carotid arteries atherosclerosis disease prevalence: systematic review and a meta-analysis. PLoS One (2014) 0.86
Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity. Oncologist (2012) 0.79
Carotid and vertebral artery stenosis evaluated by contrast-enhanced MR angiography in nasopharyngeal carcinoma patients after radiotherapy: a prospective cohort study. Br J Radiol (2015) 0.78
Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol (1999) 12.42
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Second primary neoplasms in patients with retinoblastoma. Br J Cancer (1986) 3.57
Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ (1994) 3.52
Incidence of second primary tumours among childhood cancer survivors. Br J Cancer (1987) 3.26
Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol (1975) 3.12
Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol (1994) 2.94
Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol (2009) 2.73
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2001) 2.71
The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma. Int J Cancer (1982) 2.71
Immunotherapy for acute myelogenous leukaemia. Br J Cancer (1973) 2.67
Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol (1999) 2.57
The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology (2000) 2.51
The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J (2000) 2.34
Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment. J Clin Oncol (2000) 2.29
Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival. Br J Ophthalmol (1988) 2.18
Expression of human T and B lymphocyte cell-surface markers on leukaemic cells. Lancet (1974) 2.15
The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol (1988) 2.05
Delay in diagnosis of retinoblastoma: risk factors and treatment outcome. Br J Ophthalmol (1999) 1.82
An orbital period of 0.94 days for the hot-Jupiter planet WASP-18b. Nature (2009) 1.79
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti-CD20): a retrospective cohort analysis. Br J Haematol (2001) 1.79
Late deaths and survival after childhood cancer: implications for cure. BMJ (1994) 1.76
The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis. Ann Oncol (2007) 1.76
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy. Br J Cancer (2000) 1.74
The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer. Ann Oncol (2011) 1.73
A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer. J Clin Oncol (1989) 1.72
Emotional support for cancer patients: what do patients really want? Br J Cancer (1996) 1.72
Spleen size: how well do linear ultrasound measurements correlate with three-dimensional CT volume assessments? Br J Radiol (2002) 1.71
Magnetic resonance imaging of fistula-in-ano. Dis Colon Rectum (1994) 1.68
The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol (2000) 1.68
Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Lancet (1983) 1.66
Array-based DNA methylation profiling in follicular lymphoma. Leukemia (2009) 1.63
Ultrasonography in the diagnosis of renal obstruction. BMJ (1990) 1.62
Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. BMJ (1992) 1.61
Durable remissions of myelodysplastic syndrome and acute myeloid leukemia after reduced-intensity allografting. J Clin Oncol (2003) 1.59
Central nervous system toxicity of interferon. Br J Cancer (1983) 1.58
Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin Cancer Res (1996) 1.57
The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol (1991) 1.55
CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol (2000) 1.55
Renal function after high dose urography in patients with renal failure. Br J Radiol (1981) 1.52
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial. J Clin Oncol (1985) 1.51
Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care. Anaesthesia (2005) 1.50
Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol (1995) 1.48
High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Ann Oncol (1998) 1.48
Late deaths after treatment for childhood cancer. Arch Dis Child (1990) 1.46
Post-operative serial prostate-specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate. Br J Urol (1995) 1.46
Influence of fructose concentration on myocardial infarction in senile diabetic and non-diabetic patients. Exp Clin Endocrinol Diabetes (2009) 1.46
MVPP chemotherapy regimen for advanced Hodgkin's disease. Br Med J (1978) 1.46
Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/5. Blood (1994) 1.44
Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. Br J Cancer (1977) 1.43
Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim. Genet Med (2001) 1.43
Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol (2000) 1.43
HLA-DP based resistance to Hodgkin's disease. Lancet (1989) 1.42
Angio-immunoblastic lymphadenopathy: report of ten cases and review of the literature. Q J Med (1979) 1.42
Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol (1994) 1.41
Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse. Am J Pathol (1983) 1.40
Apparent removal of graft-versus-leukaemia effect by the use of leucocyte-poor blood components in patients with acute myeloblastic leukaemia. Br J Haematol (1989) 1.40
Long-term effects of nasoalveolar molding on three-dimensional nasal shape in unilateral clefts. Cleft Palate Craniofac J (1999) 1.36
Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation. Br J Ophthalmol (2009) 1.35
Phase II study of vinorelbine in patients with malignant pleural mesothelioma. J Clin Oncol (2000) 1.35
Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol (1986) 1.34
An intelligent framework for the classification of the 12-lead ECG. Artif Intell Med (1999) 1.33
Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol (2007) 1.33
Advanced neuroblastoma: improved response rate using a multiagent regimen (OPEC) including sequential cisplatin and VM-26. J Clin Oncol (1984) 1.30
Frequency of the Bcl-2/IgH rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol (2001) 1.28
A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion. Cancer Chemother Pharmacol (1982) 1.26
Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. Eur J Endocrinol (2003) 1.26
Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer (1998) 1.26
Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type. Br Med J (1978) 1.25
Breast cancer screening: racial/ethnic differences in behaviors and beliefs. J Cancer Educ (1995) 1.23
The use of peroxidase-labelled antiglobulin for ultrastructural localization of tissue antigens reacting with serum antibodies. J Immunol Methods (1973) 1.23
Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study. Leukemia (2007) 1.22
Blast crisis of chronic myeloid leukaemia (CML). II. Cell surface marker analysis of "lymphoid" and myeloid cases. Br J Haematol (1976) 1.22
Renal involvement in patients with non-Hodgkin's lymphoma: clinical and pathological features in 23 cases. Hematol Oncol (1990) 1.21
Histological transformation of non-Hodgkin's lymphoma: a prospective study. Cancer (1979) 1.18
Magnetic resonance imaging of anal fistulae. Lancet (1992) 1.17
Meta-analysis to evaluate the role of interferon in follicular lymphoma. J Clin Oncol (2005) 1.17
Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma. Leukemia (2007) 1.17
Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia. Nature (1987) 1.16
CT appearances of desmoid tumours in familial adenomatous polyposis: further observations. Clin Radiol (1994) 1.15
Embryology of the adrenal glands and its relevance to diagnostic imaging. Clin Radiol (2005) 1.15
Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy. Br Med J (1974) 1.15
Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML. Leukemia (2007) 1.14
The peritoneum, mesenteries and omenta: normal anatomy and pathological processes. Eur Radiol (1998) 1.14
Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy. Br Med J (Clin Res Ed) (1988) 1.14
Ectopic intracranial retinoblastoma in childhood. Br J Ophthalmol (1985) 1.14
Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome. Eur J Endocrinol (2003) 1.13
Prevention of generalized reactions to contrast media: a consensus report and guidelines. Eur Radiol (2001) 1.12
Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. J Clin Oncol (2001) 1.12
Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20-year period. Ann Oncol (1995) 1.12
Liver tumours. Eur J Cancer (1999) 1.11
The pre-operative assessment of advanced gastric cancer by computed tomography. Br J Surg (1984) 1.11